NTPC & NIIF sign MoU to explore business opportunities together
NTPC & NIIF sign MoU to explore business opportunities together

NTPC & NIIF sign MoU to explore business opportunities together

DSIJ Intelligence Article rating: 5.0

This partnership intends to bring together the technical expertise of NTPC as well as NIIF’s ability to raise capital with the help of its relationship with the leading players thereby, bringing the best of global practices.

Zensar company Foolproof launches end-to-end digital offering
Zensar company Foolproof launches end-to-end digital offering

Zensar company Foolproof launches end-to-end digital offering

DSIJ Intelligence Article rating: 3.0

Zensar Technologies acquired company-Foolproof announced the launch of Infinity CRO, a conversion rate optimisation product focussed on helping businesses improve their digital real estate, focus marketing spend and make significant returns on digital.

Zydus Cadila receives USFDA nod for manufacturing Doxycycline injection
Zydus Cadila receives USFDA nod for manufacturing Doxycycline injection

Zydus Cadila receives USFDA nod for manufacturing Doxycycline injection

DSIJ Intelligence Article rating: 4.1

On Thursday, pharma company Zydus Cadila announced that it has received approval from United States Food and Drug Administration (USFDA) for its supplemental abbreviated new drug application (SANDA) for Doxycycline Injection USP, 100mg/vial.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 3.7

The market opened in the green on July 16, 2020, overall volumes in futures & options currently stand at 3,53,96,076 crore contracts with a turnover of Rs. 21,50,273.38 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 4.0

The market opened in the green on July 16, 2020, overall volumes in futures & options currently stand at 3,53,96,076 crore contracts with a turnover of Rs. 21,50,273.38 crore.

RSS
First29362937293829392941294329442945Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR